Juan Carlos Hernandez-Boluda

University of Valencia

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Alexandros Rampotas

Oxford University Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Vikas Gupta

CANADA

View details

ROSA MARIA AYALA DIAZ

Full Professor

Universidad Complutense de Madrid

SPAIN

View details

Sergio Giralt

Chief Attending, Adult BMT Service

Memorial Sloan Kettering Cancer Center

UNITED STATES

View details

Donal P. McLornan

UNITED KINGDOM

View details

Daniele Avenoso

Professore Associato

University of Brescia

ITALY

View details

Francisca Ferrer‐Marín

SPAIN

View details

Muhammad Bilal Abid

UNITED STATES

View details

Jose Carlos Martinez Avila

Profesor Ayudante Doctor

Universidad Politécnica de Madrid

SPAIN

View details

Nicolaus Kröger

GERMANY

View details

Valentin Garcia

Profesor Asociado

Universidad de Alcalá

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Juan Carlos Hernandez-Boluda

Research Interests

Explore related searches

Contact this professor

Articles (10)

Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

Adoptive Immunotherapy via Donor Lymphocyte Infusions following Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: A Real-World, Retrospective Multicenter Study

Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping

Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors

Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of Myelofibrosis

CNL and aCML should be considered as single entity based on molecular profiles and outcomes.

An evaluation of asciminib for patients with chronic myeloid leukemia previously treated with ≥2 tyrosine kinase inhibitors

Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis

Collaborators (11)

Alexandros Rampotas

Vikas Gupta

ROSA MARIA AYALA DIAZ

Sergio Giralt

Donal P. McLornan

Daniele Avenoso

Francisca Ferrer‐Marín

Muhammad Bilal Abid

Jose Carlos Martinez Avila

Nicolaus Kröger

Valentin Garcia

Make your next move.